Kalkine has a fully transformed New Avatar.

Last update at 2026-03-11T00:10:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
ASX Stocks Estimated To Be Up To 48.3% Below Intrinsic Value
Tue 09 Dec 25, 07:34 PM3 ASX Stocks That Could Be Trading Below Their Estimated Value In November 2025
Wed 12 Nov 25, 07:34 PMASX Value Stock Opportunities For September 2025
Sun 21 Sep 25, 07:35 PMASX Penny Stocks To Watch With Market Caps Under A$200M
Fri 01 Aug 25, 03:05 AMCleanSpace Holdings (ASX:CSX) investors are sitting on a loss of 38% if they invested a year ago
Tue 03 May 22, 09:29 PMCleanSpace Holdings (ASX:CSX) Knows How To Allocate Capital Effectively
Mon 10 Jan 22, 08:48 PMThe past year for CleanSpace Holdings (ASX:CSX) investors has not been profitable
Fri 22 Oct 21, 12:07 AMMany Still Looking Away From CleanSpace Holdings Limited (ASX:CSX)
Mon 30 Aug 21, 02:32 AM| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Income before tax | -1.03308M | -4.58955M | -11.82657M | -15.27697M | 15.96M |
| Minority interest | - | - | - | - | - |
| Net income | -0.47828M | -3.12714M | -8.13159M | -11.28144M | 11.39M |
| Selling general administrative | 3.59M | 12.05M | 18.45M | 17.14M | 16.02M |
| Selling and marketing expenses | 1.02M | 1.56M | - | 4.05M | 3.68M |
| Gross profit | 14.78M | 11.36M | 8.41M | 9.75M | 40.27M |
| Reconciled depreciation | 0.92M | 0.96M | 1.04M | 1.02M | 1.13M |
| Ebit | -1.28095M | -4.44883M | -11.83134M | -15.13143M | 16.01M |
| Ebitda | -0.82455M | -3.49180M | -10.62730M | -14.11498M | 17.15M |
| Depreciation and amortization | 0.46M | 0.96M | - | 1.02M | 1.13M |
| Non operating income net other | - | - | - | - | - |
| Operating income | -1.28095M | -4.74341M | -11.81980M | -15.13143M | 16.01M |
| Other operating expenses | 21.05M | 20.54M | - | 28.48M | 34.01M |
| Interest expense | 0.09M | 0.14M | 0.16M | 0.16M | 0.00822M |
| Tax provision | -0.55480M | -1.46241M | -3.69498M | -3.99553M | 4.57M |
| Interest income | 0.34M | 0.37M | 0.00677M | 0.06M | 0.07M |
| Net interest income | 0.25M | 0.22M | -0.00677M | -0.20684M | -0.06874M |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 0.55M | -1.46241M | -3.69498M | -3.99553M | 4.57M |
| Total revenue | 19.76M | 15.72M | 12.09M | 13.36M | 49.93M |
| Total operating expenses | 16.06M | 16.17M | - | 24.87M | 24.35M |
| Cost of revenue | 4.99M | 4.36M | 3.69M | 3.61M | 9.66M |
| Total other income expense net | 0.25M | 0.15M | 0.00905M | 0.05M | 0.11M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | -0.47828M | -3.12714M | -8.13159M | -11.28144M | 11.39M |
| Net income applicable to common shares | -0.47828M | -3.12714M | -8.13159M | -11.28144M | 11.39M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Total assets | 27.57M | 26.05M | 28.98M | 38.36M | 50.72M |
| Intangible assets | - | - | - | - | - |
| Earning assets | - | - | - | - | - |
| Other current assets | - | 0.41M | 1.24M | 3.48M | 0.48M |
| Total liab | 8.41M | 6.95M | 7.02M | 8.60M | 9.99M |
| Total stockholder equity | 19.16M | 19.10M | 21.96M | 29.75M | 40.73M |
| Deferred long term liab | - | - | - | - | - |
| Other current liab | - | 2.57M | 1.55M | 3.41M | 4.34M |
| Common stock | - | 33.55M | 33.44M | 33.43M | 33.43M |
| Capital stock | 33.87M | - | 33.44M | 33.43M | 33.43M |
| Retained earnings | -15.49403M | -15.17476M | -12.23304M | -4.15700M | 6.76M |
| Other liab | - | - | 0.36M | 0.42M | 0.47M |
| Good will | - | - | - | - | - |
| Other assets | - | 0.00000M | 6.31M | 0.90M | 1.06M |
| Cash | 2.52M | 2.75M | 3.12M | 8.22M | 22.21M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 3.62M | 3.76M | 3.30M | 7.02M | 7.92M |
| Current deferred revenue | - | 0.04M | - | - | 4.33M |
| Net debt | 0.31M | 0.70M | - | -4.09396M | -17.82448M |
| Short term debt | - | 0.53M | 0.00000M | 2.97M | 2.78M |
| Short long term debt | - | - | 0.15M | 2.53M | 2.37M |
| Short long term debt total | - | 3.45M | - | 4.13M | 4.38M |
| Other stockholder equity | - | - | 0.75M | 0.48M | 0.53M |
| Property plant equipment | - | - | 2.40M | 3.44M | 3.85M |
| Total current assets | 18.38M | 17.64M | 20.26M | 33.99M | 45.77M |
| Long term investments | - | - | - | - | - |
| Net tangible assets | - | - | 21.95M | 29.73M | 40.69M |
| Short term investments | 7.95M | 7.02M | 9.04M | 16.08M | 16.03M |
| Net receivables | 3.52M | 4.59M | 3.32M | 2.47M | 2.44M |
| Long term debt | 2.83M | - | 2.68M | - | 0.00293M |
| Inventory | 2.25M | 2.87M | 2.99M | 3.74M | 4.61M |
| Accounts payable | 0.71M | 0.62M | 0.26M | 0.64M | 0.80M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | - | 0.73M | - | 0.48M | 0.53M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | - | - |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | - | -0.00000M | - | - | - |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 9.19M | 8.41M | 8.72M | 4.36M | 4.95M |
| Capital lease obligations | 1.70M | - | 1.16M | 1.60M | 2.01M |
| Long term debt total | - | - | 3.36M | 1.16M | 1.60M |
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Investments | -0.77838M | 2.00M | 7.04M | -0.04374M | -12.45809M |
| Change to liabilities | - | - | -4.02448M | 0.48M | -2.75069M |
| Total cashflows from investing activities | -0.77838M | 2.00M | 7.06M | -0.62800M | -14.18492M |
| Net borrowings | - | -0.15404M | -0.21149M | -0.35795M | -2.89190M |
| Total cash from financing activities | -0.55987M | -0.63709M | -0.21149M | -0.35795M | 16.19M |
| Change to operating activities | - | - | 0.07M | -0.11553M | 0.35M |
| Net income | -0.47828M | -3.12714M | -8.13159M | -11.28144M | 11.39M |
| Change in cash | -0.22756M | -0.36810M | -5.10887M | -13.98243M | 15.46M |
| Begin period cash flow | 2.75M | 3.12M | 8.22M | 22.21M | 6.74M |
| End period cash flow | 2.52M | 2.75M | 3.12M | 8.22M | 22.21M |
| Total cash from operating activities | 1.11M | -1.72683M | -11.96072M | -12.99648M | 13.46M |
| Issuance of capital stock | - | - | - | - | 19.08M |
| Depreciation | 0.92M | 0.96M | 1.02M | 1.00M | 1.11M |
| Other cashflows from investing activities | 0.26M | 2.03M | 7.07M | -0.02217M | -12.45809M |
| Dividends paid | - | - | - | - | - |
| Change to inventory | 0.61M | 0.12M | 0.75M | 0.72M | -3.49503M |
| Change to account receivables | -0.68624M | -0.02385M | -0.95223M | -0.01281M | 6.21M |
| Sale purchase of stock | - | - | - | 0.00000M | 19.08M |
| Other cashflows from financing activities | -0.02599M | -0.48305M | - | -0.62800M | -0.55492M |
| Change to netincome | - | - | 0.41M | 0.54M | 1.27M |
| Capital expenditures | 0.10M | 0.03M | 0.00526M | 0.61M | 1.73M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | -0.04537M | 0.17M | 0.08M | -0.10080M | -5.36747M |
| Stock based compensation | 0.41M | 0.27M | - | - | - |
| Other non cash items | 0.30M | 0.00400M | - | - | - |
| Free cash flow | 1.01M | -1.75691M | -11.96598M | -0.60583M | -1.72683M |
Sector: Healthcare Industry: Medical Devices
| Company | Change (AUD) | Price (AUD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| CSX Cleanspace Holdings Ltd |
-0.025 4.76% | 0.50 | 25.00 | - | 1.99 | 1.93 | 1.59 | 12.97 |
| COH Cochlear Ltd |
-2.015 1.10% | 180.50 | 35.04 | 28.33 | 5.17 | 6.50 | 5.41 | 22.39 |
| 4DX 4DMEDICAL Ltd |
0.04 0.90% | 4.47 | - | - | 421.18 | 37.59 | 411.50 | -7.2899 |
| AVR Anteris Technologies Global Corp |
0.28 3.26% | 8.87 | - | - | 495.24 | 162.25 | 283.45 | -5.1986 |
| PNV Polynovo Ltd |
0.03 2.78% | 0.93 | 92.50 | 30.40 | 4.58 | 7.52 | 4.45 | 89.43 |
CleanSpace Holdings Limited designs, manufactures, and sells respirators and related products and services for people working in industrial and healthcare environments in the United Kingdom, rest of Europe, the Asia Pacific, North America, and internationally. The company offers CleanSpace HALO, which provides an elevated level of respiratory protection in healthcare environments; CleanSpace CST PRO, a technology that keeps protected and connected; CleanSpace CST ULTRA, an intelligent powered air purifying respirator (PAPR) system that provides protection reporting for safety compliance; CleanSpace EX, a PAPR for explosive atmospheres; and CleanSpace Work, an industrial PAPR for high dust environments. It also provides accessories and consumable products, such as masks, filters, and docking stations. The company was founded in 2009 and is based in St Leonards, Australia.
39 Herbert Street, St Leonards, NSW, Australia, 2065
| Name | Title | Year Born |
|---|---|---|
| Dr. Alexandra Birrell | CEO & Exec. Director | NA |
| Ms. Elizabeth Harvey | CFO & Joint Company Sec. | NA |
| Mr. Dan Kao | Director of Operations & Exec. Director | NA |
| Mr. Alex Virr | Chief Technology Officer | NA |
| Mr. Jon Imms | Global Sales Director | NA |
| Ms. Elissa Hansen | Joint Company Sec. | NA |
| Mr. Graham A. McLean CPA, CIMA | CEO & Director | 1965 |
| Mr. Dan Kao | Director of Innovation & Operations and Executive Director | NA |
| Ms. Bree Greeff | Interim Chief Financial Officer | NA |
| Mr. Graham A. McLean CPA, CIMA | CEO & Director | 1965 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.